TACT is a partner of choice for companies in the pharmaceutical field
With its experienced and specialized team in the pharmaceutical field, TACT is a preferred partner to help companies in this sector establish themselves, stand out and navigate the regulated markets of Québec and Canada.
Cutting-Edge Expertise, for the Benefit of Patients
TACT supports pharmaceutical companies that wish to maximize and advance patient access to adequate and safe treatments and vaccines. As a strategic partner, TACT collaborates in the implementation of innovative and sustainable solutions to make public and private services more accessible at the local, regional, national, or international levels. This involves close collaboration with patient groups and healthcare professionals to identify needs, develop appropriate strategies, and implement various initiatives.
Our Services
The TACT team supports its clients so that they can evolve successfully in a constantly changing market. Our experts design market access strategies, analyze and optimize data to produce favourable recommendations, and support the market introduction processes for drugs and vaccines as well as the evaluation processes for private or public reimbursement.
TACT has a deep understanding of drug regulations and public policies and can also advise and assist you in your dealings with the authorities. By collaborating with TACT, pharmaceutical companies can further benefit from our extensive network of decision-makers, partners, and resources, as well as our commitment to staying abreast of new trends in the industry and business environment, and legislative and regulatory changes.
TACT Rx, a training service specialized in health
TACT Rx, the new identity of the USOP Rx platform founded in 2018 by Dan Cooper, is dedicated to optimizing medication use and is now expanding its horizons.
TACT Rx is a training service specialized in health for healthcare professionals, the pharmaceutical and healthcare technology industries, pharmaceutical companies, patient associations, and other groups and organizations wishing to deepen their knowledge and skills in the field of health technology evaluation.
TACT Rx training courses are designed to enhance your knowledge and skills in a rapidly changing healthcare innovation environment. They cover four areas: access and reimbursement challenges, government relations and market access, the health technology evaluation (HTA) process, and methodological training. This comprehensive approach integrates scientific, clinical, and pharmacoeconomic dimensions and is consistent with public reimbursement and optimal use of treatments.
Our training courses provide a better understanding of access and evaluation mechanisms and strengthen your ability to analyze and interpret data that informs coverage decisions in Quebec and elsewhere in Canada. They also provide knowledge about market access and strategies adapted to a constantly evolving healthcare system.
TACT Rx’s mission
To educate and train healthcare professionals and the health technology industry in the clinical and pharmacoeconomic evaluation of drugs and medical devices in the context of reimbursement and optimal use, while stimulating reflection on the challenges and refining strategies related to market access.
Our Expertise
In-depth expertise to meet the specific needs of the pharmaceutical industry
TACT banks on recognized expertise in pharmacology, pharmaco-economics, drug and health technology assessment, market access strategies, negotiating reimbursement agreements, pharmaceutical business and industry association management and planning, government relations with stakeholders, health policies and data science.
Our experts’ top-notch issue resolution skills, in-depth understanding of the Canadian and Québec governments and health systems, and ability to adapt to rapidly changing industry trends make them essential allies for pharmaceutical companies seeking a true partner to assist them in operations, compliance, profitability, and patient health impact.
